Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF/Pten mouse melanoma model
Open Access
- 7 February 2024
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 18 (4) , 969-987
Abstract
Immunotherapies for malignant melanoma seek to boost the anti‐tumoral response of CD8+ T cells, but have a limited patient response rate, in part due to limited tumoral immune cell infiltration. Genetic or pharmacological inhibition of the pannexin 1 (PANX1) channel‐forming protein is known to decrease melanoma cell tumorigenic properties in vitro and ex vivo. Here, we crossed Panx1 knockout (Panx1−/−) mice with the inducible melanoma model BrafCA, PtenloxP, Tyr::CreERT2 (BPC). We found that deleting the Panx1 gene in mice does not reduce BRAF(V600E)/Pten‐driven primary tumor formation or improve survival. However, tumors in BPC‐Panx1−/− mice exhibited a significant increase in the infiltration of CD8+ T lymphocytes, with no changes in the expression of early T‐cell activation marker CD69, lymphocyte activation gene 3 protein (LAG‐3) checkpoint receptor, or programmed cell death ligand‐1 (PD‐L1) in tumors when compared to the BPC‐Panx1+/+ genotype. Our results suggest that, although Panx1 deletion does not overturn the aggressive BRAF/Pten‐driven melanoma progression in vivo, it does increase the infiltration of effector immune T‐cell populations in the tumor microenvironment. We propose that PANX1‐targeted therapy could be explored as a strategy to increase tumor‐infiltrating lymphocytes to boost anti‐tumor immunity.Keywords
All Related Versions
Funding Information
- Canadian Institutes of Health Research (FRN 153112)
This publication has 58 references indexed in Scilit:
- Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanomaOncoImmunology, 2012
- Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing FactorsJournal of Oncology, 2012
- β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient MelanomasCancer Cell, 2011
- In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of MelanomaCell, 2011
- Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosisNature, 2010
- Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptorsJournal of Leukocyte Biology, 2010
- Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumoursMelanoma Research, 2010
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- CellProfiler™: Free, Versatile Software for Automated Biological Image AnalysisBioTechniques, 2007
- Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell linesOncogene, 2004